4//SEC Filing
Burns John Thomas 4
Accession 0001104659-21-033294
CIK 0001390478other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:28 PM ET
Size
16.5 KB
Accession
0001104659-21-033294
Insider Transaction Report
Form 4
Transactions
- Award
Stock Option (Right to Buy)
2021-03-04+17,250→ 17,250 totalExercise: $8.00Exp: 2031-03-04→ Common Stock (17,250 underlying) - Award
Common Stock
2021-03-04+2,875→ 12,875 total
Footnotes (2)
- [F1]The Reporting Person received an award of 2,875 restricted stock units on March 4, 2021, which shall vest as follows: (i) 25% on December 1, 2021 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date.
- [F2]One-quarter (1/4) of the option shares will vest and became exercisable one year from the March 4, 2021 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.
Issuer
SELLAS Life Sciences Group, Inc.
CIK 0001390478
Entity typeother
Related Parties
1- filerCIK 0001568734
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 4:28 PM ET
- Size
- 16.5 KB